Literature DB >> 15888485

Genomic architecture of human 17q21 linked to frontotemporal dementia uncovers a highly homologous family of low-copy repeats in the tau region.

Marc Cruts1, Rosa Rademakers, Ilse Gijselinck, Julie van der Zee, Bart Dermaut, Tim de Pooter, Peter de Rijk, Jurgen Del-Favero, Christine van Broeckhoven.   

Abstract

Familial frontotemporal dementia (FTD), characterized by tau-negative, ubiquitin-positive inclusions at autopsy, is linked to a chromosomal region at 17q21 (FTDU-17), encompassing the gene encoding the microtubule associated protein tau, MAPT. Mutations in MAPT were previously identified in familial FTD with parkinsonism (FTDP-17); however, in FTDU-17 patients, no pathogenic mutations were found in exonic regions consistent with the lack of tauopathy in FTDU-17 brains. Here, we excluded mutations in MAPT by genomic sequencing of 138.5 kb in FTDU-17 patients. Next, to facilitate the identification of the actual underlying genetic defect, we assembled the 6.5 Mb FTDU-17 sequence. Annotation demonstrated that MAPT is surrounded by three highly homologous low-copy repeats (LCRs) in a region of 1.7 Mb. Using evolutionary studies, short tandem repeat-based linkage disequilibrium (LD) and macro-restriction mapping, we demonstrated that these LCRs are at the basis of a series of rearrangements in the MAPT genomic region. One is an inversion that occurred 3 million years ago and resulted in a common polymorphism in humans to date. This inversion plus flanking LCRs spanned approximately 1.3 Mb and was shown to underlie the extended LD and haplotypes H1 and H2 across MAPT. However, in the FTDU-17 families, we ascertained segregation analysis precluding a relationship between the FTDU-17 and the H1/H2 inversion. The presence of multiple homologous LCRs in the region predicts that other potentially more complex genomic rearrangements might be underlying FTDU-17.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15888485     DOI: 10.1093/hmg/ddi182

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  26 in total

Review 1.  Frontotemporal dementia.

Authors:  Erik D Roberson
Journal:  Curr Neurol Neurosci Rep       Date:  2006-11       Impact factor: 5.081

2.  Analysis of segmental duplications reveals a distinct pattern of continuation-of-synteny between human and mouse genomes.

Authors:  Michael R Mehan; Maricel Almonte; Erin Slaten; Nelson B Freimer; P Nagesh Rao; Roel A Ophoff
Journal:  Hum Genet       Date:  2006-11-08       Impact factor: 4.132

3.  Structural and functional characterization of H2 haplotype MAPT promoter: unique neurospecific domains and a hypoxia-inducible element would enhance rationally targeted tauopathy research for Alzheimer's disease.

Authors:  Bryan Maloney; Debomoy K Lahiri
Journal:  Gene       Date:  2012-01-30       Impact factor: 3.688

4.  Polymorphic micro-inversions contribute to the genomic variability of humans and chimpanzees.

Authors:  Justyna M Szamalek; David N Cooper; Werner Schempp; Peter Minich; Matthias Kohn; Josef Hoegel; Violaine Goidts; Horst Hameister; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2005-12-16       Impact factor: 4.132

5.  The distribution and most recent common ancestor of the 17q21 inversion in humans.

Authors:  Michael P Donnelly; Peristera Paschou; Elena Grigorenko; David Gurwitz; Syed Qasim Mehdi; Sylvester L B Kajuna; Csaba Barta; Selemani Kungulilo; N J Karoma; Ru-Band Lu; Olga V Zhukova; Jong-Jin Kim; David Comas; Marcello Siniscalco; Maria New; Peining Li; Hui Li; Vangelis G Manolopoulos; William C Speed; Haseena Rajeevan; Andrew J Pakstis; Judith R Kidd; Kenneth K Kidd
Journal:  Am J Hum Genet       Date:  2010-01-28       Impact factor: 11.025

6.  Identification of a novel risk locus for progressive supranuclear palsy by a pooled genomewide scan of 500,288 single-nucleotide polymorphisms.

Authors:  Stacey Melquist; David W Craig; Matthew J Huentelman; Richard Crook; John V Pearson; Matt Baker; Victoria L Zismann; Jennifer Gass; Jennifer Adamson; Szabolcs Szelinger; Jason Corneveaux; Ashley Cannon; Keith D Coon; Sarah Lincoln; Charles Adler; Paul Tuite; Donald B Calne; Eileen H Bigio; Ryan J Uitti; Zbigniew K Wszolek; Lawrence I Golbe; Richard J Caselli; Neill Graff-Radford; Irene Litvan; Matthew J Farrer; Dennis W Dickson; Mike Hutton; Dietrich A Stephan
Journal:  Am J Hum Genet       Date:  2007-03-08       Impact factor: 11.025

Review 7.  The genetics of frontotemporal lobar degeneration.

Authors:  Rosa Rademakers; Mike Hutton
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

8.  H2 haplotype at chromosome 17q21.31 protects against childhood sexual abuse-associated risk for alcohol consumption and dependence.

Authors:  Elliot C Nelson; Arpana Agrawal; Michele L Pergadia; Jen C Wang; John B Whitfield; F Scott Saccone; Jason Kern; Julia D Grant; Andrew J Schrage; John P Rice; Grant W Montgomery; Andrew C Heath; Alison M Goate; Nicholas G Martin; Pamela A F Madden
Journal:  Addict Biol       Date:  2010-01       Impact factor: 4.280

9.  Current experimental therapy for Alzheimer's disease.

Authors:  Sheng Chen; Xiao-Jie Zhang; Liang Li; Wei-Dong Le
Journal:  Curr Neuropharmacol       Date:  2007       Impact factor: 7.363

Review 10.  Functional MAPT haplotypes: bridging the gap between genotype and neuropathology.

Authors:  Tara M Caffrey; Richard Wade-Martins
Journal:  Neurobiol Dis       Date:  2007-05-05       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.